Showing results (1951-1960 of 3,830) with videos related to

Sort By:
Pageof 383
The American Surgeon|September 26, 2003
The predictive value of preliminary bacterial colony counts from bronchoalveolar lavage in critically ill trauma patientsEric W Mueller, G Christopher Wood, Mark S Kelley, et al.
The Journal of Trauma|January 28, 2005
Effect from multiple episodes of inadequate empiric antibiotic therapy for ventilator-associated pneumonia on morbidity and mortality among critically ill trauma patientsEric W Mueller, Scott D Hanes, Martin A Croce, et al.
Cancer Research|August 3, 2005
WW domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional functionRami I Aqeilan, Valentina Donati, Alexey Palamarchuk, et al.
Breast Cancer Research : BCR|November 3, 2006
GATA3 protein as a MUC1 transcriptional regulator in breast cancer cellsMartín C Abba, María I Nunez, Andrea G Colussi, et al.
Oncogene|July 12, 2005
HMGA1 protein expression sensitizes cells to cisplatin-induced cell deathGustavo Baldassarre, Barbara Belletti, Sabrina Battista, et al.
The American Surgeon|January 16, 2007
The effect of bacterial contamination on neointimal hyperplasia in vascular graftsNorma M Edwards, Jeffrey A Claridge, Dan H Shell, et al.
Database : the Journal of Biological Databases and Curation|November 19, 2019
Identification of tRNA-derived ncRNAs in TCGA and NCI-60 panel cell lines and development of the public database tRFexplorerAlessandro La Ferlita, Salvatore Alaimo, Dario Veneziano, et al.
Journal of Biological Regulators and Homeostatic Agents|January 2, 2021
Sensorized assessment of bilateral hand movements in patients with stroke driven by rhythmic auditory or visual-auditory stimulationS Ghanbari Ghooshchy, M Iosa, I Ciancarelli, et al.
Physical Chemistry Chemical Physics : PCCP|July 23, 2013
Structural characterization and thermal and chemical stability of bioactive molecule-hydrotalcite (LDH) nanocompositesEleonora Conterosito, Gianluca Croce, Luca Palin, et al.
Plos One|March 6, 2013
Cost-utility analysis of lopinavir/ritonavir versus atazanavir + ritonavir administered as first-line therapy for the treatment of HIV infection in Italy: from randomised trial to real worldEmanuela Foglia, Paolo Bonfanti, Giuliano Rizzardini, et al.
Pageof 383